Novonix (NVX) Common Equity (2020 - 2025)

Novonix (NVX) has 6 years of Common Equity data on record, last reported at $161.7 million in Q4 2025.

  • For Q4 2025, Common Equity rose 17.5% year-over-year to $161.7 million; the TTM value through Dec 2025 reached $161.7 million, up 17.5%, while the annual FY2025 figure was $161.7 million, 17.5% up from the prior year.
  • Common Equity reached $161.7 million in Q4 2025 per NVX's latest filing, up from $137.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $261.0 million in Q2 2022 and bottomed at $137.6 million in Q4 2024.
  • Average Common Equity over 5 years is $185.4 million, with a median of $172.8 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 218.89% in 2021, then decreased 25.2% in 2024.
  • A 5-year view of Common Equity shows it stood at $142.0 million in 2021, then soared by 59.2% to $226.1 million in 2022, then dropped by 18.63% to $183.9 million in 2023, then fell by 25.2% to $137.6 million in 2024, then rose by 17.5% to $161.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $161.7 million in Q4 2025, $137.6 million in Q4 2024, and $183.9 million in Q4 2023.